These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Biomarkers for Alzheimer's disease: current status and prospects for the future. Blennow K, Zetterberg H. J Intern Med; 2018 Dec; 284(6):643-663. PubMed ID: 30051512 [Abstract] [Full Text] [Related]
8. Cerebrospinal Fluid Markers of Neurodegeneration and Rates of Brain Atrophy in Early Alzheimer Disease. Tarawneh R, Head D, Allison S, Buckles V, Fagan AM, Ladenson JH, Morris JC, Holtzman DM. JAMA Neurol; 2015 Jun; 72(6):656-65. PubMed ID: 25867677 [Abstract] [Full Text] [Related]
9. Combining cerebrospinal fluid and PI-2620 tau-PET for biomarker-based stratification of Alzheimer's disease and 4R-tauopathies. Dilcher R, Wall S, Groß M, Katzdobler S, Wagemann O, Palleis C, Weidinger E, Fietzek U, Bernhardt A, Kurz C, Ferschmann C, Scheifele M, Zaganjori M, Gnörich J, Bürger K, Janowitz D, Rauchmann BS, Stöcklein S, Bartenstein P, Villemagne V, Seibyl J, Sabri O, Barthel H, Perneczky R, Schöberl F, Zwergal A, Höglinger GU, Levin J, Franzmeier N, Brendel M. Alzheimers Dement; 2024 Oct; 20(10):6896-6909. PubMed ID: 39263969 [Abstract] [Full Text] [Related]
10. Ante mortem cerebrospinal fluid tau levels correlate with postmortem tau pathology in frontotemporal lobar degeneration. Irwin DJ, Lleó A, Xie SX, McMillan CT, Wolk DA, Lee EB, Van Deerlin VM, Shaw LM, Trojanowski JQ, Grossman M. Ann Neurol; 2017 Aug; 82(2):247-258. PubMed ID: 28719018 [Abstract] [Full Text] [Related]
12. Characterization of novel CSF Tau and ptau biomarkers for Alzheimer's disease. Meredith JE, Sankaranarayanan S, Guss V, Lanzetti AJ, Berisha F, Neely RJ, Slemmon JR, Portelius E, Zetterberg H, Blennow K, Soares H, Ahlijanian M, Albright CF. PLoS One; 2013 Aug; 8(10):e76523. PubMed ID: 24116116 [Abstract] [Full Text] [Related]
13. Non-beta-amyloid/tau cerebrospinal fluid markers inform staging and progression in Alzheimer's disease. Gangishetti U, Christina Howell J, Perrin RJ, Louneva N, Watts KD, Kollhoff A, Grossman M, Wolk DA, Shaw LM, Morris JC, Trojanowski JQ, Fagan AM, Arnold SE, Hu WT. Alzheimers Res Ther; 2018 Sep 25; 10(1):98. PubMed ID: 30253800 [Abstract] [Full Text] [Related]
19. Systemic and central nervous system metabolic alterations in Alzheimer's disease. van der Velpen V, Teav T, Gallart-Ayala H, Mehl F, Konz I, Clark C, Oikonomidi A, Peyratout G, Henry H, Delorenzi M, Ivanisevic J, Popp J. Alzheimers Res Ther; 2019 Nov 28; 11(1):93. PubMed ID: 31779690 [Abstract] [Full Text] [Related]